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Nedd4-2-dependent Mechanism*
Ste´phanie Michlig‡, Michael Harris‡, Johannes Loffing§, Bernard C. Rossier‡, and Dmitri Firsov‡1
From the ‡De´partement de Pharmacologie et de Toxicologie, Universite´ de Lausanne, 27, rue du Bugnon, CH-1005 Lausanne and
the §De´partement de Me´dicine, Unite´ d’Anatomie, Universite´ de Fribourg, CH-1700 Fribourg, Switzerland
Activation of the mitogen-activated protein (MAP) kinase cas-
cade by progesterone in Xenopus oocytes leads to a marked down-
regulation of activity of the amiloride-sensitive epithelial sodium
channel (ENaC). Here we have studied the signaling pathways
involved in progesterone effect on ENaC activity. We demonstrate
that: (i) the truncation of the C termini of the ENaC subunits
results in the loss of the progesterone effect on ENaC; (ii) the effect
of progesterone was also suppressed by mutating conserved tyro-
sine residues in the Pro-X-X-Tyr (PY)motif of theC termini of the
and  ENaC subunits (Y618A and Y628A); (iii) the down-regulation
of ENaC activity by progesterone was also suppressed by co-expres-
sion ENaC subunits with a catalytically inactivemutant of Nedd4-2,
a ubiquitin ligase that has beenpreviously demonstrated todecrease
ENaC cell-surface expression via a ubiquitin-dependent internal-
ization/degradation mechanism; (iv) the effect of progesterone was
significantly reduced by suppression of consensus sites (T613A and
T623A) for ENaC phosphorylation by the extracellular-regulated
kinase (ERK), aMAP kinase previously shown to facilitate the bind-
ing of Nedd4 ubiquitin ligases to ENaC; (v) the quantification of
cell-surface-expressed ENaC subunits revealed that progesterone
decreases ENaC open probability (whole cell Po, wcPo) and not its
cell-surface expression. Collectively, these results demonstrate that
the binding of active Nedd4-2 to ENaC is a crucial step in themech-
anism of ENaC inhibition by progesterone. Upon activation of ERK,
the effect of Nedd4-2 on ENaC open probability can become more
important than its effect on ENaC cell-surface expression.
The amiloride-sensitive epithelial sodiumchannel (ENaC)2 is a highly
selectiveNa channel found in the apicalmembrane of salt-reabsorbing
tight epithelia, including the kidney distal nephron, the distal colon, the
salivary and sweat glands, and the lung. ENaC activity is essential for
maintaining extracellular fluid volume and blood pressure. The activity
of this channel is controlled at two levels: the number of active channels
on the cell surface (N) and the channel open probability (Po) (1). How-
ever, quantitative estimates of N and Po values remain difficult, mainly
because of the low cell-surface expression and high variability of the
open probability of ENaC. Aldosterone, the principal hormone control-
ling ENaC activity, has been shown to have a major effect on N. One of
the molecular mechanisms proposed for the regulation of ENaC cell-
surface expression by aldosterone involvesNedd4-2 ubiquitin ligase and
serum- and glucocorticoids-induced kinase isoform 1 (sgk1). In amodel
proposed by Debonneville et al. (2) for the principal cell of the kidney
collecting duct, binding of Nedd4-2 to the Pro-X-X-Tyr (PY) motif in
the  and  ENaC subunits results in ENaC ubiquitylation and intracel-
lular degradation. Stimulation of sgk1 expression by aldosterone pro-
vokes sgk1-dependent Nedd4-2 phosphorylation, resulting in a
decreased binding affinity of Nedd4-2 to ENaC and, finally, in an
increased ENaC number at the cell surface. However, recent evidence
indicates that increased sgk1 expression may also be involved in the
regulation of ENaC Po. Diakov et al. (3) have shown that sgk1 can
directly phosphorylate the C terminus of the ENaC subunit, and that
this phosphorylation significantly increases ENaC activity via an
increase in channel Po. Alvarez de la Rosa et al. (4) have recently dem-
onstrated that expression of a constitutively active mutant of sgk1 in A6
cells results in a significant increase of both N and Po. Using measure-
ments of wcPo, a similar dual effect of sgk1 on ENaC N and Po was
observed by Vuagniaux et al. (5) in Xenopus oocyte expression system.
We have also shown that a naturally occurringmutation of the PYmotif
(R564stop), which causes an autosomal dominant form of salt-sensitive
hypertension (Liddle syndrome), results in both an increase in N and
predominant change in Po (6). Collectively, these data indicate that
sgk1- and/or Nedd4-2-dependent mechanisms may control ENaC
activity by controlling both the N and Po.
Another mechanism known to play an important role in the control
of ENaC activity is the extracellular signal-regulated protein kinases 1
and 2 (ERK1/2) signaling pathway. This signaling pathway is thought to
have a dual effect on ENaC. The long term (hours/days) activation of
this pathway leads to the down-regulation of ENaC activity via inhibi-
tion of the transcription rate of ENaC subunits (7, 8). The short term
(minutes) activation of ERK1/2 also down-regulates ENaC activity. The
molecular mechanism responsible for this acute effect remains poorly
understood. Shi et al. (9) have shown that ERK is capable of directly
phosphorylating the  and  ENaC subunits on residues Thr-613 and
Thr-623, respectively. The phosphorylation ofT613 andT623 increases
the affinity of WW domains of Nedd4–1 ubiquitin ligase (a closely
related homologue of Nedd4-2) for the C termini of the  and  sub-
units. T613A and T623A mutations significantly increased the INa, but
whether changes in N and/or Po were responsible for this increase was
not determined (9). We have recently shown that activation of ERK
pathway by progesterone in Xenopus oocytes leads to a marked down-
regulation of ENaC activity (10). However, our data did not fit well with
a Nedd4-2-dependent ENaC ubiquitylation/degradation mechanism,
because quantification of ENaC expression at the cell surface revealed
that themain effect of progesterone is a decrease of channel Po. The aim
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of the present study was to analyze the molecular mechanisms of the
observed Po effect. Detailed analysis of the progesterone effect on ENaC
activity demonstrated, contrary to our expectations, that the regulation
of ENaC Po by progesterone is PY motif- and Nedd4-2-dependent.
These results demonstrate a novel mode of action of Nedd4-2 in the
regulation of channel function by Po.
EXPERIMENTAL PROCEDURES
Expression of ENaC and Nedd4-2 in Xenopus oocytes—Complemen-
tary RNAs for rat  ENaC subunits, human Nedd4-2, and mouse
NaPi-IIa sodium phosphate co-transporter were synthesized in vitro
using SP6 polymerase. The cRNAs were injected into Xenopus oocytes
(10 ng of total cRNA/oocyte), and injected oocytes were kept in modi-
fied Barth solution (MBS) containing 88 mM NaCl, 1 mM KCl, 2.4 mM
NaHCO3, 0.8 mM MgSO4, 0.3 mM Ca(NO3)2, 0.4 mM CaCl2, 10 mM
Hepes-NaOH (pH 7.2). Electrophysiological measurements and cell
surface biotinylation were performed 24 h after injection. Macroscopic
amiloride-sensitive Na current (INa) was defined as the difference
between Na current obtained in the presence (5 M) and in the
absence of amiloride and was recorded, using the two-electrode voltage
clamp method. The mean INa values in different oocyte batches ranged
between 1 and 15 A.
Biotinylation of ENaC Subunits on the Cell Surface—Biotinylation
was performed in 48-well plates, using 20 oocytes per experimental
condition. All biotinylation steps were performed in a cold room, using
ice-cold solutions. After incubation in ice-coldMBS solution for 30min,
the oocytes were washed three times withMBS. After the last wash, the
MBS solution was removed and replaced by a biotinylation buffer con-
taining 10 mM triethanolamine, 150 mM NaCl, 2 mM CaCl2, 1 mg/ml
EZ-link sulfo-NHS-SS-Biotin (Pierce), pH 9.5. The incubation lasted 15
min with gentle agitation. The biotinylation reaction was stopped by
washing the oocytes two timeswith aQuench buffer containing 192mM
glycine, 25 mM Tris-Cl (pH 7.5) added to the MBS solution. After the
second wash, oocytes were incubated for 5 min in the Quench buffer
with gentle agitation. Oocytes were then washed two times with the
MBS solution and transferred to 1.5-ml Eppendorf tubes. Oocytes were
lysed by repeated pipetting with Pasteur pipettes in a lysis buffer con-
taining: 1%TritonX-100, 500mMNaCl, 5mMEDTA, 50mMTris-Cl (20
l/oocyte). The lysates were vortexed for 30 s, and the mixture was
centrifuged for 10 min at 12,000 rpm. Supernatants were transferred to
the new 1.5-ml Eppendorf tubes containing 50 l of immunopure
immobilized streptavidin beads (Pierce) washed with lysis buffer. After
overnight incubation at 4 °C with shaking, the tubes were centrifuged
for 1 min at 5000 rpm. Supernatant was removed, and beads were
washed three times with lysis buffer. 60 l of SDS-PAGE sample buffer
was added to the beads. All samples were heated for 5 min at 95 °C
before loading on the 8% SDS-PAGE.
Antibodies—The anti-ENaC antibodies were previously described.
The anti-actin antibody was from Sigma.
ENaC Phosphorylation Assay—For maximal loading of oocytes with
[32P]orthophosphate (H3PO4), the oocytes were co-injected with
FLAG-taggedENaC andNaPiIIa sodium phosphate co-transporter
cRNAs. 24 h after injection, 20 oocytes/experimental condition were
transferred to the 2-ml Eppendorf tubes. MBS was removed and
replaced by 100 l/tube MBS solution complemented with 250 Ci of
[32P]orthophosphate (Hartmann). Oocytes were incubated for 3 h at
19 °C, washed three times with MBS, and lysed in the lysis buffer con-
taining: 80 mM NaCl, 1 mM MgCl2, 10 mM HEPES (pH 7.4), 1 mM
phenylmethylsulfonyl fluoride, 100 mM NaF, 10 mM disodium pyro-
phosphate, 20 M sodium orthovanadate. The lysates were centrifuged
for 10 min at 2,500 rpm. Supernatants were transferred to the 1.5-ml
Eppendorf tubes and centrifuged for 20 min at 10,000 rpm. Superna-
tants were discarded, and pellets were solubilized in a buffer containing:
0.5% digitonin, 100 mMNaCl, 20 mMTris-HCl, 2 mM phenylmethylsul-
fonyl fluoride, 100 mM NaF, 10 mM disodium pyrophosphate, 20 M
sodium orthovanadate. Immunoprecipitation was performed in non-
denaturing conditions with monoclonal anti-FLAG antibody (Sigma),
as described (6). Sampleswere run on 8–13%SDS-PAGE, and phospho-
rylation of ENaC subunits was revealed by autoradiography.
RESULTS
The Effect of Progesterone on ENaC Activity Is PY Motif- and
Nedd4-2-dependent—As shown in Fig. 1, the addition of progesterone
(15 M) to ENaC-expressing oocytes leads to a significant down-regu-
lation of amiloride-sensitive Na current (INa). The INa is inhibited rap-
idly; 50% of INa inhibition is reached within 30 min of progesterone
treatment. The short-time required for INa inhibition indicated that
ENaC activity and/or cell-surface expression, rather than cRNA stabil-
ity or protein synthesis, are regulated by progesterone. This was con-
firmed by the stable expression of ENaC subunit proteins, over 4 h
of treatmentwith progesterone (see below). To assess which parts of the
ENaC subunits are involved in channel responsiveness to progesterone,
we first expressedENaC subunits with truncated C termini. For the
 truncationwe used amutant inwhich all C-terminal amino acidswere
eliminated (R618stop  T). For the  and  subunits truncation, we
used the R564stop (T) and W574stop (T) mutants that cause Liddle
disease (11). As shown in Fig. 2A, the truncation of  C termini
results in a complete loss of the progesterone effect on ENaC. Because
the PY motifs in the C termini of  and  subunits have been demon-
strated as the important regulatory elements of ENaC activity, we next
assessed the effect of progesterone on theY618A andY628Amutants. As
shown in Fig. 2B, themutation of the PYmotifs in both and subunits,
either alone or together, resulted in the complete suppression of the
progesterone effect on ENaC. This result clearly demonstrated that the
progesterone effect on ENaC is dependent on PY motif of either  or 
(but not ) ENaC subunits. The PY motifs have been proposed to bind
various WW-domain-containing proteins, including dystrophin,
caveolins, ubiquitin ligases, and other proteins (12). Also, Shimkets et al.
(13) have proposed that  and  PYmotifs are required for clathrin-de-
pendent ENaC endocytosis. Because ENaC interaction with Nedd4-2
has been shown to be an importantmechanism controlling ENaC activ-
ity, we next tested the effect of the catalytically inactive Nedd4-2C145S
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FIGURE1.Progesterone rapidlydown-regulatesENaCactivity.Oocyteswere injected
with ENaC cRNAs. The INa was measured by the voltage-clamp technique, 24 h after
cRNA injection. Progesterone was dissolved in EtOH and tested at 15 M concentration
(0.15% EtOH). The equivalent amount of EtOHwas added to the control oocytes. Shown
aremean S.E. of three independent experiments eachperformedwith five oocytes per
experimental condition. *, statistical significance of0.05.
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mutant (Nedd4-2CS mutant) on channel activity. As shown in Fig. 2C,
co-expression of ENaCwith theNedd4-2CSmutant leads to a complete
loss of the progesterone effect. As expected, PY mutations (Fig. 2B) or
co-expression with the Nedd4-2CS mutant (Fig. 2C) both resulted in a
significant increase in INa. Collectively, these experiments demon-
strated that elimination of Nedd4-2 binding domains in ENaC subunits
or suppression of endogenous ubiquitin ligase activity by expression of
the Nedd4-2CS mutant lead to the abolishment of the progesterone
effect on ENaC.
The Effect of Progesterone on ENaCActivity Is Reduced byMutation of
the Consensus Sites for ERK Phosphorylation—Recently, several amino
acids lying outside the PY motifs have been proposed to be involved in
the interaction between ENaC and Nedd4-2 (9, 14). For instance, Shi et
al. (9) have shown that phosphorylation of Thr-613 and Thr-623 by
ERK facilitates the interaction between ENaC and WW-domains of
Nedd4–1 ubiquitin ligase, a closely related homolog of Nedd4-2.
Because the effect of progesterone on ENaC depends on the activation
of the ERK pathway (10), we also tested the effect of these two phospho-
rylation sites on progesterone inhibition of INa. As shown in Fig. 3A, the
mutation of Thr-613 and/or Thr-623 to alanine results in a partial
but significant reduction of the progesterone effect on INa. These muta-
tions also resulted in a significant increase in basal INa: 8.8  2.3-fold
increase for T613AT623A channel (p  0.01, compared with 
channel); 2.7 0.6-fold increase for T613A channel (p 0.05, com-
pared with  channel); and 2.5 0.8-fold increase for T613AT623A
channel (p  0.05, compared with  channel). To check whether
progesterone induces ERK-dependent ENaC phosphorylation, we
attempted 32P-phosphorylation experiments in living oocytes. How-
ever, our first experiments revealed only low, almost undetectable levels
of ENaC phosphorylation (data not shown). This was probably due to a
low uptake of [32P]orthophosphate across the oocyte plasmamembrane
under standard conditions. To improve oocyte loading with
[32P]orthophosphate, we co-injected ENaC subunits with NaPiIIa
sodium phosphate co-transporter. As shown in Fig. 3B, co-injection
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FIGURE 2. Progesterone down-regulates ENaC activity via PY motifs and Nedd4-2-
dependent mechanism. A, expression of ENaC subunits with truncated C termini
(R618stopR564stopR574stop) resulted in the loss of the progesterone effect on INa.
Oocytes were treated with 15 M for 4 h. Shown are mean S.E. of eight independent
experiments each performed with five oocytes per experimental condition. *, statistical
significance of 0.05. B, expression of ENaC subunits with mutated PY motifs in 
(Y618A) and  (Y628A) subunits also results in the loss of the progesterone effect on INa.
Oocytes were treated with 15M for 4 h. Shown are mean S.E. of eleven independent
experiments each performed with five oocytes per experimental condition. *, statistical
significance of 0.05. C, co-expression of ENaC with a catalytically inactive mutant of
Nedd4-2 (Nedd4-2CS) results in abolishment of the progesterone effect on INa. Oocytes
were treated with 15 M for 4 h. Shown are mean S.E. of fifteen independent experi-
ments each performed with five oocytes per experimental condition. *, statistical signif-
icance0.05. **, statistical significance of0.001.
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FIGURE 3.-Tyr-613and-Tyr-623 residues are involved in theprogesteroneeffect
on ENaC. A, expression of -Tyr-613 (T613A) or -Tyr-623 (T623A) mutants results in a
significant reduction of the inhibitory effect of progesterone on INa. Shown are mean
S.E. of eleven independent experiments each performed with five oocytes per experi-
mental condition. **, statistical significance of0.001. B, progesterone increases phos-
phorylation of the ENaC subunit. Oocytes were co-injected with FLAG-tagged
ENaC cRNAs and NaPiIIa cRNA. 24 h after injection, oocytes were loaded for 4 h with
[32P]orthophosphate. Immunoprecipitation was performed in non-denaturing condi-
tions, using anti-FLAG antibody. C, progesterone-induced phosphorylation of ENaC is
abolished in Y618A mutant. Oocytes were co-injected with NaPiIIa cRNA and ENaC
or Y618AENaC FLAG-tagged cRNAs. 24 h after injection, oocytes were loaded for 4 h
with [32P]orthophosphate. Immunoprecipitationwasperformed innon-denaturingcon-
ditions, using anti-FLAG antibody.
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with NaPiIIa allowed the detection of ENaC phosphorylation after
co-immunoprecipitation of all three  subunits in non-denaturing
conditions. Statistical analysis of six independent experiments revealed
a 30  8% (p  0.05) increase in ENaC phosphorylation under pro-
gesterone treatment. Mutation of Thr-613 to alanine significantly
reduced the basalENaCphosphorylation and abolished progesterone-
dependentENaCphosphorylation (Fig. 3C). The phosphorylation of
and  ENaC subunits was not detectable, potentially due to the complex
pattern of  and  ENaC processing by endogenous proteases (see
below). Collectively, these results demonstrate that elimination of
extra-PY motif binding sites for Nedd4 ubiquitin ligases reduces the
effect of progesterone on ENaC.
Development of a New Assay for Quantification of Channel N—It has
been proposed that the main effect of Nedd4-2 on ENaC activity con-
sists of the reduction of channelN. However, our previous experiments
demonstrated that themain effect of progesterone is a decrease of chan-
nel wcPo (10). The effect of progesterone on wcPo was previously deter-
mined, using an assay based on the binding of an iodinated monoclonal
antibody to a FLAG epitope introduced in the extracellular loops of
ENaC subunits (6). To avoid some difficulty inherent to a binding
assay, we have developed an independent procedure to quantitate N.
This procedure is based on the biotinylation of cell-surface-expressed
ENaC subunits (see “Experimental Procedures”). The biotinylated pro-
teins were precipitated with streptavidin-agarose beads and electro-
phoresed through SDS-PAGE. In parallel, 10% of intracellular proteins
recovered after precipitation of biotinylated proteinswere loaded on the
same gel. The proteins were blotted with anti-, anti-, and anti-
ENaC antibodies. As a control for the biotinylation procedure, the same
blots were re-probed with an anti-actin antibody. To validate this pro-
cedure, we quantified the cell-surface expression of the wild-type chan-
nel and the channel composed of thewild-type and subunits and the
 subunit with mutated PY motif (Y628A mutant). The use of the 
subunit rather than the  subunit mutant was chosen, because the
epitope for the anti- subunit antibody encompassed the PY motif. As
shown in Fig. 4A, the anti- antibody specifically recognizes several
molecular species of the subunit expressed at the cell surface: a band of
82 kDa corresponding to the glycosylated form of full-length ENaC
protein, a band of65 kDa and the double bands of25 kDa. Because
the epitope for this antibody is located in theN-terminal part ofENaC,
the double bands of25 kDa could correspond to theN-terminal prod-
ucts of furin-dependent ENaC cleavage described by Hughey et al.
(15). The 65-kDa band represents an as-yet uncharacterized ENaC
protein species, but could correspond to a species of65 kDa observed
in airway cells, using a similar protocol and the same antibody (16, 17).
The intensity of both the82-kDa band and the25-kDa double bands
was significantly increased in the Y628A channel, whereas the inten-
sity of the 65-kDa band remained unchanged. In the intracellular
protein pool, the anti- antibody specifically recognizes two ENaC
species; one, which is identical to the65-kDa band of the cell-surface-
expressed subunit and the second one, which ismigrating at78 kDa.
A possible explanation for the difference between ENaC migration
profile in the biotinylated and non-biotinylated protein pools consists of
the presence in the intracellular pool of important amounts of yolk
proteinsmigrating in a range of molecular masses of80–100 kDa (see
Ponceau red protein staining in Fig. 4D). This large amount of yolk
proteins in oocytes could be a confounding factor for the migration of
other intracellular proteins in this range of molecular masses, including
the 82-kDa band of ENaC.
As shown in Fig. 4B, the anti- antibody specifically recognizes two
molecular species of ENaC expressed at the cell surface: a major band
of 110 kDa that corresponds to the glycosylated form of full-length
ENaC protein and an as-yet uncharacterized minor band of75 kDa.
The intensity of both 95-kDa and 75-kDa bands was significantly
increased in Y628A channel. In the intracellular protein pool, the
ENaC antibody recognizes two bands: one, which is identical to the
minor75-kDa band, and the second one, migrating at100 kDa. As
discussed above, the difference in migration profiles of cell surface and
intracellular ENaC potentially comes from the interference between
ENaC and yolk proteins migration. As shown in Fig. 4C, probing of
biotinylated proteins with an anti-ENaC antibody reveals a 85-kDa
band corresponding to the glycosylated form of full-length ENaC pro-
tein and the double bands of63 kDa. These double bands could cor-
respond to the furin-cleaved ENaC described by Hughey et al. (15).
Cell surface expression of both the  65-kDa band and the 63-kDa
double bands was significantly increased in Y628A mutant channel.
Probing of intracellular proteins with the anti- antibody revealed that
this antibody strongly cross-reacts with oocyte yolk proteins. Impor-
tantly, only intracellular protein pools were positive for anti-actin stain-
ing, thus demonstrating that only cell-surface-expressed proteins were
biotinylated in our experiments (Fig. 4E). The absence of the 25-kDa
FIGURE 4.Cell surface biotinylation of ENaC subunits. A, cell-surface biotinylated pro-
teins (left panel) and an intracellular protein pool (right panel) were probed with an anti-
ENaC antibody. This antibody recognizes an N-terminal epitope in the ENaC subunit.
B, cell-surface biotinylated proteins (left panel) and an intracellular protein pool (right
panel) were probedwith an anti-ENaC antibody. This antibody recognizes a C-terminal
epitope in the ENaC subunit. C, cell-surface biotinylated proteins (left panel) as well as
intracellular protein pool (right panel) were probed with an anti-ENaC antibody. This
antibody recognizes a C-terminal epitope in ENaC subunit. D, Ponceau red staining of
Western blotmembrane reveals amajor band of oocyte yolk proteinsmigrating in 80- to
100-kDa range of molecular masses. This band potentially interferes with the migration
of  subunits in the intracellular protein pool. E, probing of the same Western blot
with an anti-actin antibody demonstrates that cell-surface biotinylated proteins are not
contaminated by the intracellular proteins.
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ENaC species and a low amount of the 63-kDa ENaC species in the
intracellular pool of proteins (Fig. 4,A and C, respectively) indicate that
only a minor fraction of cell-surface-expressed  and  ENaC subunits
remains non-biotinylated.
Collectively, these experiments demonstrated that the anti-, anti-,
and anti- ENaC antibodies can be used for Western blot detection of
cell-surface-expressed ENaC subunits. These experiments also indicate
that quantitative analysis of Western blots can be used for the quantifi-
cation of ENaC expression at the cell surface. However, a complex pat-
tern of molecular species for  and  subunits could potentially reduce
the precision of estimates for these subunits. Thus, for quantitative
analysis of ENaC at the cell surface, we used the  subunit, which is
represented by a singe major band of95 kDa. As shown in Fig. 5, the
Y628A channel exhibits 3.13-fold increased INa, as comparedwith the
wild-type channel, whereas cell-surface expression is increased only by
2.18-fold. These results fit well with the previously observed double
effect of the Liddle mutation on N and Po (6) and, thus, validate the use
of biotinylation for quantification of ENaC expression at the cell surface.
Progesterone Down-regulates ENaC Activity by Decreasing Channel
Po—To assess themechanism of the progesterone effect on ENaC activ-
ity, we performed a parallel analysis of INa and cell-surface expression of
ENaC in oocytes treated with progesterone. As shown in Fig. 6A, 4-h
treatment with progesterone resulted in a 80% inhibition of INa. Bio-
tinylation experiments presented in Fig. 6B revealed no significant dif-
ference for ENaC expression, neither at the cell surface, nor in the
intracellular pool. Paired statistical analysis of nine independent exper-
iments revealed a 20% non-significant reduction in N in oocytes
treated with progesterone (Fig. 6C). Interestingly, we have previously
observed a 20% non-significant reduction of N under progesterone
treatment by the antibody binding assay (10). Collectively, these results
demonstrate that the major effect of progesterone is the decrease of
channel wcPo.
DISCUSSION
Nedd4-2 Has Two Distinct Effects on ENaC Function in the Xenopus
Oocyte Expression System—Ubiquitylation is a common post-transla-
tional modification, consisting in the covalent transfer of one or multi-
ple copies of ubiquitin, a 76-amino acid protein, to the target proteins.
Although ubiquitylation is usually considered as a signal for protein
degradation by the proteasome, the attachment of ubiquitin can also
regulate protein localization and/or activity, independent of proteolysis.
For example, ubiquitylation has been shown to act as a regulated local-
ization signal for nuclear or integral membrane proteins (reviewed in
Ref. 18). Ubiquitylation has also been demonstrated to control the activ-
ity of components of the endocytic machinery, the activity of transcrip-
tion factors and the kinase activity (reviewed in Ref. 19).
Ubiquitylation is a multiple step reaction in which attachment of
ubiquitin to the target proteins is catalyzed by ubiquitin protein ligases,
or E3 enzymes. Numerous studies have demonstrated that Nedd4-2, an
E3 enzyme, is capable of ubiquitylation of ENaC subunits (20, 21). This
ubiquitylation has been proposed to down-regulate the activity of ENaC
by decreasing the number of active channels (N) at the cell surface
(22–24). This hypothesis implies that binding of Nedd4-2 to C-terminal
PY motifs leads to ubiquitylation and degradation of ENaC subunits
through the ubiquitin-26 S proteasome pathway. This hypothesis, how-
ever, does not take into account the fact that the suppression of ENaC-
Nedd4-2 interaction in a Liddle syndrome mutant also results in a par-
allel increase in channel wcPo (6). To explain this double effect of PY
mutation, one might propose either the existence of a Nedd4-2-inde-
FIGURE 5. Dual effect of the Y628A mutation on N and Po. Expression of Y628A
results in a 3.130.35-fold increase in INa,whereas theparallel quantificationofWestern
blots revealed only a 2.18 0.25 increase in ENaC cell-surface expression. Shown are
mean S.E. of twenty-five independent experiments each performed with five oocytes
per experimental condition. *, statistical significance of0.05.
FIGURE6.Progesteronedown-regulates ENaCPo.A, progesterone significantly down-
regulates INa. Oocytes were injected with ENaC cRNAs. After injection, the oocytes
were incubated inMBS solution for 24 h. Oocyteswere treated for 4 hwith progesterone
(15 mM) before INa measurement. Shown are mean  S.E. of nine independent experi-
ments each performed with five oocytes per experimental condition. *, statistical signif-
icance of0.001. B, Western probing of cell surface (left panel) and intracellular proteins
(right panel) demonstrates that there is no significant change inENaC expression upon
progesterone treatment. C, statistical treatment (t test) of nine independent biotinyla-
tion experiments demonstrated that there is no significant difference in the cell-surface
expression of the ENaC subunit between untreated oocytes and oocytes treated with
progesterone. ShownaremeanS.E. of nine independent experiments eachperformed
with 20 oocytes per biotinylation.
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pendent, but PYmotif-dependentmechanism, regulating channel Po, or
alternatively, the involvement of Nedd4-2 in regulating both N and Po.
Our present study favors the latter, showing that Nedd4-2 can be
directly involved in the regulation of ENaC Po. In Xenopus oocytes, the
activationoftheMAPkinasecascadebyprogesteroneleadstotheNedd4-2-
dependent decrease in channel wcPo. Importantly, this effect of proges-
terone requires both Nedd4-2 binding to ENaC via PY motifs and
Nedd4-2 catalytic activity. BecauseNedd4-2 binding to PYmotifs is also
required for regulation of channel N, the difference may arise from the
amino acids lying outside of the canonical PY motif involved in ENaC-
Nedd4-2 binding. Our data demonstrate that Thr-613 and/or Thr-
623 are required for the full effect of progesterone on ENaC. Shi et al. (9)
have shown that phosphorylation of these amino acids by ERK facili-
tates ENaC-Nedd4 interaction. One may propose that these additional
binding sites may be responsible for the novel effect of Nedd4-2 on
channel Po. Alternatively, progesterone treatment may lead to Nedd4-
2-dependent ubiquitylation of non-ENaC proteins. Also, we cannot for-
mally rule out the possibility that progesterone affects the channel con-
ductance, but it is, at present, a very unlikely possibility, because the C
terminus of either  or  ENaC subunit is located far away from the
channel pore region. All mutations of the C termini so far studied have
changed either N and/or Po but not channel conductance.
Previously, several lysine residues in N-terminal parts of  and 
ENaC subunits have been identified as the targets for Nedd4-2-depend-
ent ubiquitylation (25). The major effect of the mutation of these lysine
residues was an increase of channelN. Whether ubiquitylation of other
lysines may influence the mode of Nedd4-2 action on ENaC remains to
be established. Recently, Rajan et al. (26) have demonstrated that addi-
tion of SUMO, a ubiquitin-like protein, to a single lysine residue in the
K2P1 (TWIK) potassium channel results in a complete silencing of this
channel. Removal of SUMOby a desumoylation enzyme restored chan-
nel activity. This study provided the proof of principle that a ubiquity-
lation-like mechanism can be involved in the regulation of the open
probability of ion channels.
Hormonal Regulation of ENaC: N versus Po?—The N versus Po regu-
lation of ENaC activity in different physiological or pathophysiological
situations remains a matter of controversy (reviewed in Ref. 1). We will
briefly discuss themechanisms of ENaC regulation by aldosterone in the
context of the Liddle syndrome, because it involves a lack of interaction
between the ENaC  and  subunits with Nedd4-2.
Aldosterone-dependent Signaling Cascade—Dahlmann et al. (27)
have observed that the mineralocorticoid regulation of ENaC was fully
maintained in a mouse model of Liddle syndrome. The INa through
epithelial sodium channels was measured in the principal cell of the
cortical collecting duct (CCD) of mice expressing mutated ENaC sub-
unit. The Liddle mice had a much larger INa measured in the principal
cell when the animalswere fedwith a low sodiumdiet orwhen theywere
infusedwith aldosterone. The INa fromLiddlemicewas also largerwhen
animals were pretreated with a high potassium diet, a maneuver that
increases plasma aldosterone levels. Noise analysis of channel activity
indicated that the open probability was similar in the two genotypes.
Thus the increase in whole cell current was attributed to a difference in
the density of conducting channels, but as discussed by the authors,
their method cannot distinguish between de novo insertion of channels
into the plasmamembrane from activation of near silent channels (Po
0.05) already expressed at the surface. In addition, our own measure-
ment of wcPo (6) suggests that the number of channels that can be
measured by noise or patch clamp analysis represents only a minor
fraction of ENaCs expressed at the cell surface. Immunolocalization
studies also show a translocation of the ENaC subunit at the apical
membrane under salt restriction (28). No channel protein could be
detected by immunostaining in salt-repleted animals. Again, the appar-
ent lack of channels in the apicalmembrane of principal cells is probably
due to the difficulty to detect by immunostaining a small number of
channels, which are postulated to be expressed under a standard salt
diet. Indeed, if therewas no functional channels under this physiological
condition, one should not observe severe, life-threatening, salt-loosing
syndromes in pseudo-hypoaldosteronism type 1 patients or in mouse
models in which ENaC activity has been drastically reduced or totally
abolished (29, 30). The absence of a Po effect by aldosterone may be
methodological rather than biological. The apparent controversy will
be, however, difficult to solve as long as the measurement of whole cell
Po will be restricted to large cells (oocytes) and will remain technically
not feasible in small somatic cells (CCD principal cells)
Physiological Relevance of ERK-dependent Regulation of ENaC
Activity—What could be the physiological relevance of the present
data? To our knowledge, under physiological conditions, progesterone
does not have any significant effect on wild-type ENaC activity in the
distal nephron. However, the ERK-dependent inhibition of ENaC activ-
ity is the principal mechanism of the epidermal growth factor-induced
inhibition of transepithelial sodium transport in the kidney CCD. Shen
and Cotton (7) have shown that acute addition of epidermal growth
factor to the basolateral side of the CCD monolayer leads to a rapid
ERK1/2 phosphorylation/activation and a parallel inhibition of INa. This
effect was abolished by pretreatment of CCDmonolayers with an inhib-
itor of ERK pathway. Veizis and Cotton (31) have proposed that apical
delocalization of the epidermal growth factor receptor, leading to the
hyperactivation of ERK1/2 and the sustained inhibition of INa, can con-
tribute to the pathogenesis of an autosomal recessive form of a polycys-
tic kidney disease. Themechanismof epidermal growth factor action on
N and/or Po was not reported in these studies. Our present data indicate
that Po inhibition could be the principal mechanism.
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